<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">14482</article-id><article-id pub-id-type="doi">10.15789/2220-7619-PBA-14482</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Pediatric bacteremia and CNS infections associated with <italic>klebsiella pneumoniae</italic>: molecular genetic characteristics and clinical features</article-title><trans-title-group xml:lang="ru"><trans-title>Бактериемии и инфекции ЦНС у детей, ассоциированные с<italic> klebsiella pneumoniae</italic>: молекулярно-генетическая характеристика и клинические особенности</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4587-0902</contrib-id><name-alternatives><name xml:lang="en"><surname>Sadeeva</surname><given-names>Zulfirya Z.</given-names></name><name xml:lang="ru"><surname>Садеева</surname><given-names>Зульфиря Закиевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher, Laboratory of Molecular Microbiology</p></bio><bio xml:lang="ru"><p>младший научный сотрудник лаборатории молекулярной микробиологии</p></bio><email>zulfiryasadeeva@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4234-0209</contrib-id><name-alternatives><name xml:lang="en"><surname>Novikova</surname><given-names>Irina E.</given-names></name><name xml:lang="ru"><surname>Новикова</surname><given-names>Ирина Евгеньевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher, Laboratory of Molecular Microbiolog</p></bio><bio xml:lang="ru"><p>младший научный сотрудник лаборатории молекулярной микробиологии</p></bio><email>novikovayudina@outlook.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3896-2590</contrib-id><name-alternatives><name xml:lang="en"><surname>Lazareva</surname><given-names>Anna V.</given-names></name><name xml:lang="ru"><surname>Лазарева</surname><given-names>Анна Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Head Researcher, Laboratory of Molecular Microbiology, Head of the Microbiology Laboratory</p></bio><bio xml:lang="ru"><p>д.м.н., главный научный сотрудник лаборатории молекулярной микробиологии, зав. лабораторией микробиологии </p></bio><email>annalaz71@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9365-9143</contrib-id><name-alternatives><name xml:lang="en"><surname>Alyabyeva</surname><given-names>Natalya M.</given-names></name><name xml:lang="ru"><surname>Алябьева</surname><given-names>Наталья Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Senior Researcher, Head of the Laboratory of Experimental Immunology and Virology</p></bio><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник, зав. лабораторией экспериментальной иммунологии и вирусологии </p></bio><email>bambolinka@hotmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9418-4418</contrib-id><name-alternatives><name xml:lang="en"><surname>Karaseva</surname><given-names>Olga V.</given-names></name><name xml:lang="ru"><surname>Карасева</surname><given-names>Ольга Витальевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Head of the Department of Emergency Surgery and Pediatric Trauma; Deputy Director for Scientific Work, Head of the Department of Combined Trauma, Anesthesiology-Resuscitation</p></bio><bio xml:lang="ru"><p>д.м.н., зав. отделом неотложной хирургии и травм детского возраста ; зам. директора по научной работе, руководитель отдела сочетанной травмы, анестезиологии-реанимации</p></bio><email>karaseva.o@list.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6227-466X</contrib-id><name-alternatives><name xml:lang="en"><surname>Yanushkina</surname><given-names>Olga G.</given-names></name><name xml:lang="ru"><surname>Янюшкина</surname><given-names>Ольга Грантовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Researcher, Department of Combined Trauma</p></bio><bio xml:lang="ru"><p>научный сотрудник отделения сочетанной травмы </p></bio><email>spartak-lfc@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6051-5231</contrib-id><name-alternatives><name xml:lang="en"><surname>Verschinina</surname><given-names>Marina G.</given-names></name><name xml:lang="ru"><surname>Вершинина</surname><given-names>Марина Германовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Leading Researcher, Laboratory of Medical Genomics</p></bio><bio xml:lang="ru"><p>к.м.н., ведущий научный сотрудник лаборатории медицинской геномики </p></bio><email>labckb@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8586-7946</contrib-id><name-alternatives><name xml:lang="en"><surname>Fisenko</surname><given-names>Andrey P.</given-names></name><name xml:lang="ru"><surname>Фисенко</surname><given-names>Андрей Петрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Professor, Director </p></bio><bio xml:lang="ru"><p>д.м.н., профессор, директор </p></bio><email>fisenko@nczd.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Medical Research Center for Children’s Health of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГАУ Национальный медицинский исследовательский центр здоровья детей Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Clinical and Research Institute of Emergency Pediatric Surgery and Trauma, Department of Public Health of Moscow</institution></aff><aff><institution xml:lang="ru">НИИ неотложной детской хирургии и травматологии Департамента здравоохранения г. Москвы</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-12-11" publication-format="electronic"><day>11</day><month>12</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-12-25" publication-format="electronic"><day>25</day><month>12</month><year>2023</year></pub-date><volume>13</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>1117</fpage><lpage>1128</lpage><history><date date-type="received" iso-8601-date="2023-07-05"><day>05</day><month>07</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-12-02"><day>02</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Sadeeva Z.Z., Novikova I.E., Lazareva A.V., Alyabyeva N.M., Karaseva O.V., Yanushkina O.G., Verschinina M.G., Fisenko A.P.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Садеева З.З., Новикова И.Е., Лазарева А.В., Алябьева Н.М., Карасева О.В., Янюшкина О.Г., Вершинина М.Г., Фисенко А.П.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Sadeeva Z.Z., Novikova I.E., Lazareva A.V., Alyabyeva N.M., Karaseva O.V., Yanushkina O.G., Verschinina M.G., Fisenko A.P.</copyright-holder><copyright-holder xml:lang="ru">Садеева З.З., Новикова И.Е., Лазарева А.В., Алябьева Н.М., Карасева О.В., Янюшкина О.Г., Вершинина М.Г., Фисенко А.П.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/14482">https://iimmun.ru/iimm/article/view/14482</self-uri><abstract xml:lang="en"><p><italic>Klebsiella pneumoniae</italic> is one of the most significant and life-threatening pathogen of nosocomial infections. This opportunistic microorganism can cause infections of the bloodstream, respiratory tract, urinary tract, skin and soft tissues, inflammation of meninges of the brain and spinal cord, leading to elevated hospital mortality. The purpose of our study was a retrospective analysis of molecular genetic characteristics of <italic>K. pneumoniae</italic> isolated from blood and liquor samples as well as to describe clinical features in bacteremia and CNS infections. According to the results of assessed clinical data, <italic>K. pneumoniae</italic> isolates were selected from 64 children suffered from surgical pathology (congenital heart defects — 30%, abdominal pathology — 39%, severe combined trauma — 12%) and somatic diseases accompanied by antibacterial and/or glucocorticosteroid therapy — 14%. The minimum suppressive concentrations of antibiotics were determined by the broth micro-dilution method. Carbapenemases were detected by real time polymerase chain reaction. Virulence genes and capsule serotypes K1/K2 were assessed by multiplex PCR. Biofilms were grown using flat-bottomed polystyrene plates, followed by coloring, fixation, elution and data detection. The population diversity was assessed by multilocus sequence typing. Bacteremia and CNS infections associated with <italic>K. pneumoniae</italic> were fatal in 25% of cases. A substantial portion of the isolates demonstrated the phenotype of extremely drug resistance (XDR) — 43%, the phenotype of multidrug resistance (MDR) was shown in 16% of the isolates. The <italic>bla</italic><sub>CTX-M </sub>cephalosporinase gene was found in 85% of the strains. The main determinant of resistance to carbapenems was the <italic>bla</italic><sub>OXA-48 </sub>gene (33%); the <italic>bla</italic><sub>NDM</sub> gene was detected in 9% of strains. The combination of <italic>bla</italic><sub>OXA-48 </sub>and <italic>bla</italic><sub>NDM</sub> was found in 7% of isolates. The study of biofilm production showed that moderate ability to form biofilms was shown in 61%, strong — 21%, and weak — 15% isolates. Two isolates (3%) did not form biofilms. The virulence genes <italic>entB</italic> and <italic>mrkD</italic> were detected in 100% of isolates, <italic>ybtS</italic> — in 78%. The <italic>iutA</italic> gene was found in 18% of the strains. Two isolates showed the presence of the <italic>kfu</italic> gene. Seven isolates belonged to the K2 serotype. 27 different genotypes were found in <italic>K. pneumoniae</italic> isolates examined. The most common were: ST307 — 21%, ST395 — 12%, ST48 — 7%, ST39 — 6% and ST29 — 6%. Infections of the bloodstream and central nervous system associated with <italic>K. pneumoniae</italic> have great importance in clinical practice. This microorganism is able to long persist on biotic and abiotic surfaces, has a wide natural and acquired resistance to antibiotics.</p></abstract><trans-abstract xml:lang="ru"><p><italic>Klebsiella pneumoniae</italic> является одним из наиболее значимых и опасных для жизни возбудителей внутрибольничных инфекций. Этот оппортунистический микроорганизм может вызывать инфекции кровотока, респираторного тракта, мочевыводящих путей, кожи и мягких тканей, воспаление мозговой оболочки головного и спинного мозга, приводя к увеличению госпитальной летальности. Целью нашего исследования было ретроспективное изучение молекулярно-генетических характеристик <italic>K. pneumoniae</italic>, выделенных из образцов крови и ликвора, а также описание клинических особенностей при бактериемии и инфекции ЦНС. По результатам оценки клинических данных изоляты <italic>K. pneumoniae</italic> были выделены от 64 детей, наблюдавшихся с хирургической патологией (врожденные пороки сердца — 30%, абдоминальная патология — 39%, тяжелая сочетанная травма — 12%) и с соматическими заболеваниями, сопровождающимися антибактериальной и/или глюкокортикостероидной терапией — 14%. Минимальные подавляющие концентрации антибиотиков определяли методом серийных микроразведений в бульоне. Карбапенемазы выявляли методом полимеразной цепной реакции в режиме реального времени. Определение генов вирулентности и капсульных серотипов К1/К2 проводили методом мультиплексной ПЦР. Биопленки выращивали с использованием плоскодонных полистироловых планшетов с последующей окраской, фиксированием, элюированием и детекцией результатов. Популяционное разнообразие оценивали методом мультилокусного сиквенс-типирования. Бактериемии и инфекции ЦНС, ассоциированные с <italic>K. pneumoniae</italic>, в 25% случаев завершились летальным исходом. Значительная часть изолятов продемонстрировала фенотип широкой лекарственной устойчивости (ШЛУ) — 43%, фенотип множественной лекарственной устойчивости (МЛУ) проявили 16% изолятов. Ген цефалоспориназы <italic>bla</italic><sub>CTX-M</sub> был обнаружен у 85% штаммов. Главной детерминантой устойчивости к карбапенемам был ген <italic>bla</italic><sub>OXA-48 </sub>(33%); у 9% штаммов выявлен ген <italic>bla</italic><sub>NDM</sub>. Сочетание <italic>bla</italic><sub>OXA-48</sub> и <italic>bla</italic><sub>NDM</sub> обнаружено у 7% изолятов. Изучение продукции биопленок показало, что умеренную способность к образованию биопленок проявлял 61%, сильную — 21% и слабую — 15% изолятов. Два изолята (3%) не образовывали биопленок. Гены вирулентности <italic>entB</italic> и <italic>mrkD </italic>были выявлены у 100% изолятов, <italic>ybtS</italic> — у 78%. У 18% штаммов определялся ген <italic>iutA</italic>. Два изолята показали наличие гена <italic>kfu</italic>. К серотипу K2 принадлежали семь изолятов. У изученных нами изолятов <italic>K. pneumoniae</italic> было обнаружено 27 различных генотипов. Наиболее часто встречающимися были: ST307 — 21%, ST395 — 12%, ST48 — 7%, ST39 — 6% и ST29 — 6%. Инфекции кровотока и центральной нервной системы, ассоциированные <italic>K. pneumoniae</italic>, имеют большое значение в клинической практике. Этот микроорганизм способен длительно сохраняться на биотических и абиотических поверхностях, обладает широкой природной и приобретенной резистентностью к антибиотикам.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Klebsiella pneumoniae</kwd><kwd>bacteremia</kwd><kwd>nosocomial infections</kwd><kwd>resistance</kwd><kwd>virulence</kwd><kwd>sepsis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Klebsiella pneumoniae</kwd><kwd>бактериемия</kwd><kwd>нозокомиальные инфекции</kwd><kwd>резистентность</kwd><kwd>вирулентность</kwd><kwd>сепсис</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Новикова И.Е., Садеева З.З., Шакирзянова Р.А., Алябьева Н.М., Лазарева А.В., Карасева О.В., Вершинина М.Г., Фисенко А.П. Использование полимеразной цепной реакции для детекции генов резистентности у грамотрицательных бактерий в рутинной практике педиатрического стационара // Клиническая лабораторная диагностика. 2022. T. 67, № 3. С. 180–185. [Novikova I.E., Sadeeva Z.Z., Shakirzyanova R.A., Alyabieva N.M., Lazareva A.V., Karaseva O.V., Vershinina M.G., Fisenko A.P. The using of the polymerase chain reaction for the detection of resistance genes in gram-negative bacteria in routine practice in a pediatric hospital. Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2022, vol. 67, no. 3, pp. 180–185. (In Russ.)] doi: 10.51620/0869-2084-2022-67-3-180-185</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ahmed H.A., Ibrahim E.H.S., Abdelhaliem E., Elariny E.Y.T. Biotyping, virulotyping and biofilm formation ability of ESBL-Klebsiella pneumoniae isolates from nosocomial infections. J. Appl. Microbiol., 2022, vol. 132, no. 6, pp. 4555–4568. doi: 10.1111/jam.15563</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Bachman M.A., Oyler J.E., Burns S.H., Caza M., Lépine F., Dozois C.M., Weiser J.N. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun., 2011, vol. 79, no. 8, pp. 3309–3316. doi: 10.1128/IAI.05114-11</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Compain F., Babosan A., Brisse S., Genel N., Audo J., Ailloud F., Kassis-Chikhani N., Arlet G., Decré D. Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J. Clin. Microbiol., 2014, vol. 52, no. 12, pp. 4377–4380. doi: 10.1128/JCM.02316-14</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Diancourt L., Passet V., Verhoef J., Grimont P.A., Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol., 2005, vol. 43, no. 8, pp. 4178–4182. doi: 10.1128/JCM.43.8.4178-4182.2005</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Fursova N.K., Astashkin E.I., Gabrielyan N.I., Novikova T.S., Fedyukina G.N., Kubanova M.K., Esenova N.M., Sharapchenko S.O., Volozhantsev N.V. Emergence of five genetic lines ST395NDM-1, ST13OXA-48, ST3346OXA-48, ST39CTX-M-14, and novel ST3551OXA-48 of multidrug-resistant clinical Klebsiella pneumoniae in Russia. Microb. Drug. Resist., 2020, vol. 26, no. 8, pp. 924–933. doi: 10.1089/mdr.2019.0289</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>German G.J., Gilmour M., Tipples G., Adam H.J., Almohri H., Bullard J., Dingle T., Farrell D., Girouard G., Haldane D., Hoang L., Levett P.N., Melano R., Minion J., Needle R., Patel S.N., Rennie R., Reyes R.C., Longtin J., Mulvey M.R. Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa. Can. Commun. Dis. Rep., 2018, vol. 44, no. 1, pp. 29–34. doi: 10.14745/ccdr.v44i01a07</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Girometti N., Lewis R.E., Giannella M., Ambretti S., Bartoletti M., Tedeschi S., Tumietto F., Cristini F., Trapani F., Gaibani P., Viale P. Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Medicine (Baltimore), 2014, vol. 93, no. 17, pp. 298–309. doi: 10.1097/MD.0000000000000111</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hernández-García M., Pérez-Viso B., León-Sampedro R., Navarro-San Francisco C., López-Fresneña N., Díaz-Agero C., Morosini M.I., Ruiz-Garbajosa P., Cantón R. Outbreak of NDM-1+CTX-M-15+DHA-1-producing Klebsiella pneumoniae high-risk clone in Spain owing to an undetectable colonised patient from Pakistan. Int. J. Antimicrob. Agents, 2019, vol. 54, no. 2, pp. 233–239. doi: 10.1016/j.ijantimicag.2019.05.021</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Herridge W.P., Shibu P., O’Shea J., Brook T.C., Hoyles L. Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses. J. Med. Microbiol., 2020, vol. 69, no. 2, pp. 176–194. doi: 10.1099/jmm.0.001141</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hu D., Li Y., Ren P., Tian D., Chen W., Fu P., Wang W., Li X., Jiang X. Molecular epidemiology of hypervirulent carbapenemase-producing Klebsiella pneumoniae. Front. Cell Infect. Microbiol., 2021, vol. 11: 661218. doi: 10.3389/fcimb.2021.661218</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Hu P., Chen J., Chen Y., Zhou T., Xu X., Pei X. Molecular epidemiology, resistance, and virulence properties of Pseudomonas aeruginosa cross-colonization clonal isolates in the non-outbreak setting. Infect. Genet. Evol., 2017, vol. 55, pp. 288–296. doi: 10.1016/j.meegid.2017.09.010</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Karlsson M., Stanton R.A., Ansari U., McAllister G., Chan M.Y., Sula E., Grass J.E., Duffy N., Anacker M.L., Witwer M.L., Rasheed J.K., Elkins C.A., Halpin A.L. Identification of a Carbapenemase-producing hypervirulent Klebsiella pneumoniae Isolate in the United States. Antimicrob. Agents Chemother., 2019, vol. 63, no. 7: e00519-19. doi: 10.1128/AAC.00519-19</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Khrulnova S., Fedorova A., Frolova I., Tandilova K., Likold E., Klyasova G. Distribution of virulence genes and capsule types in Klebsiella pneumoniae among bloodstream isolates from patients with hematological malignancies. Diagn. Microbiol. Infect. Dis., 2022, vol. 104, no. 1: 115744. doi: 10.1016/j.diagmicrobio.2022</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Kochan T.J., Nozick S.H., Medernach R.L., Cheung B.H., Gatesy S.W.M., Lebrun-Corbin M., Mitra S.D., Khalatyan N., Krapp F., Qi C., Ozer E.A., Hauser A.R. Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates. BMC Infect. Dis., 2022, vol. 22, no. 1: 603. doi: 10.1186/s12879-022-07558-1</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Liu C., Du P., Xiao N., Ji F., Russo T.A., Guo J. Hypervirulent Klebsiella pneumoniae is emerging as an increasingly prevalent K. pneumoniae pathotype responsible for nosocomial and healthcare-associated infections in Beijing, China. Virulence, 2020, vol. 11, no. 1, pp. 1215–1224. doi: 10.1080/21505594.2020.1809322</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lv J., Zhu J., Wang T., Xie X., Wang T., Zhu Z., Chen L., Zhong F., Du H. The role of the two-component QseBC signaling system in biofilm formation and virulence of hypervirulent Klebsiella pneumoniae ATCC43816. Front. Microbiol., 2022, vol. 13: 817494. doi: 10.3389/fmicb.2022.817494</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Mairi A., Pantel A., Ousalem F., Sotto A., Touati A., Lavigne J.P. OXA-48-producing Enterobacterales in different ecological niches in Algeria: clonal expansion, plasmid characteristics and virulence traits. J. Antimicrob. Chemother., 2019, vol. 74, no. 7, pp. 1848–1855. doi: 10.1093/jac/dkz146</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Marques A.T., Tanoeiro L., Duarte A., Gonçalves L., Vítor J.M.B., Vale F.F. Genomic analysis of prophages from Klebsiella pneumoniae clinical Isolates. Microorganisms, 2021, vol. 9, no. 11: 2252. doi: 10.3390/microorganisms9112252</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Paczosa M.K., Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol. Mol. Biol. Rev., 2016, vol. 80, no. 3, pp. 629–661. doi: 10.1128/MMBR.00078-15</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Pan H., Lou Y., Zeng L., Wang L., Zhang J., Yu W., Qiu Y. Infections caused by carbapenemase-producing Klebsiella pneumoniae: microbiological characteristics and risk factors. Microb. Drug Resist., 2019, vol. 25, no. 2, pp. 287–296. doi: 10.1089/mdr.2018.0339</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Potron A, Poirel L, Rondinaud E, Nordmann P. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill., 2013, vol. 18, no. 31: 20549. doi: 10.2807/1560-7917.es2013.18.31.20549</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Stepanović S., Vuković D., Hola V., Di Bonaventura G., Djukić S., Cirković I., Ruzicka F. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS, 2007, vol. 115, no. 8, pp. 891–899. doi: 10.1111/j.1600-0463.2007.apm_630.x</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Wyres K.L., Holt K.E. Klebsiella pneumoniae population genomics and antimicrobial-resistant clones. Trends Microbiol., 2016, vol. 24, no. 12, pp. 944–956. doi: 10.1016/j.tim.2016.09.007</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Xu M., Fu Y., Kong H., Chen X., Chen Y., Li L., Yang Q. Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome. BMC Infect. Dis., 2018, vol. 18, no. 1: 358. doi: 10.1186/s12879-018-3263-x</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Yang Y., Yang Y., Chen G., Lin M., Chen Y., He R., Galvão K.N., El-Gawad El-Sayed Ahmed M.A., Roberts A.P., Wu Y., Zhong L.L., Liang X., Qin M., Ding X., Deng W., Huang S., Li H.Y., Dai M., Chen D.Q., Zhang L., Liao K., Xia Y., Tian G.B. Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China. Emerg. Microbes. Infect., 2021, vol. 10, no. 1, pp. 700–709. doi: 10.1080/22221751.2021.1906163</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Yuan Y., Wang J., Yao Z., Ma B., Li Y., Yan W., Wang S., Ma Q., Zhang J., Xu J., Li L., Wang Y., Fan E. Risk factors for Carbapenem-resistant Klebsiella pneumoniae bloodstream infections and outcomes. Infect. Drug. Resist., 2020, vol. 13, pp. 207–215. doi: 10.2147/IDR.S223243</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Zhang S., Zhang X., Wu Q., Zheng X., Dong G., Fang R., Zhang Y., Cao J., Zhou T. Clinical, microbiological, and molecular epidemiological characteristics of Klebsiella pneumoniae-induced pyogenic liver abscess in southeastern China. Antimicrob. Resist. Infect. Control, 2019, vol. 8: 166. doi: 10.1186/s13756-019-0615-2</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Zheng X., Wang J.F., Xu W.L., Xu J., Hu J. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit. Antimicrob. Resist. Infect. Control, 2017, vol. 6: 102. doi: 10.1186/s13756-017-0256-2</mixed-citation></ref></ref-list></back></article>
